Cargando…

The Role of Antifungals in Pediatric Critical Care Invasive Fungal Infections

Invasive fungal infections (IFIs) have seen considerable increase in pediatric intensive care units over the past several decades. IFIs are predominantly caused by Candida species, and candidemia is the third most common cause of healthcare-associated bloodstream infections (BSIs) in children. IFIs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaushik, Ashlesha, Kest, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282141/ https://www.ncbi.nlm.nih.gov/pubmed/30595916 http://dx.doi.org/10.1155/2018/8469585

Ejemplares similares

Pediatric Methicillin-Resistant Staphylococcus aureus Osteoarticular Infections
por: Kaushik, Ashlesha, et al.
Publicado: (2018)

Sexual Behavior and Knowledge among Adolescents with Perinatally Acquired Human Immunodeficiency Virus Infection Compared to HIV-Uninfected Adolescents at an Urban Tertiary Center in New Jersey
por: Kaushik, Ashlesha, et al.
Publicado: (2016)

It Is Complicated: The Medico-Social Journey of an Undocumented Pregnant Adolescent
por: Kest, Helen, et al.
Publicado: (2020)

Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection
por: Kest, Helen, et al.
Publicado: (2020)

Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections
por: Lamoth, Frederic, et al.
Publicado: (2020)

Epidemiologic Characteristics of Adolescents with COVID-19 Disease with Acute Hypoxemic Respiratory Failure
por: Kest, Helen, et al.
Publicado: (2022)

The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review
por: Chakrabarti, Arunaloke, et al.
Publicado: (2022)

Adolescents as partners in the fight against COVID-19
por: Kest, Helen, et al.
Publicado: (2022)

Role of New Antifungal Agents in the Treatment of Invasive Fungal Infections in Transplant Recipients: Isavuconazole and New Posaconazole Formulations
por: Li, Julius, et al.
Publicado: (2015)

Severe Enteritis as the Sole Manifestation of Novel Coronavirus Disease 2019 (COVID-19) in Adolescent Patients
por: Gupta, Sandeep, et al.
Publicado: (2020)

Combination antifungal treatment in critically ill patients failing first-line therapy for invasive fungal infections
por: Pagani, L, et al.
Publicado: (2006)

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies
por: Gamaletsou, Maria N., et al.
Publicado: (2018)

Novel Promising Antifungal Target Proteins for Conquering Invasive Fungal Infections
por: Zhen, Cheng, et al.
Publicado: (2022)

Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections
por: Cavassin, Francelise B., et al.
Publicado: (2021)

Antifungal Resistance and New Strategies to Control Fungal Infections
por: Vandeputte, Patrick, et al.
Publicado: (2012)

Fungal infections: Pathogenesis, antifungals and alternate treatment approaches
por: Reddy, G.Kiran Kumar, et al.
Publicado: (2022)

Clinical Uses of Inhaled Antifungals for Invasive Pulmonary Fungal Disease: Promises and Challenges
por: Vuong, Nancy N., et al.
Publicado: (2023)

Role of isavuconazole in the treatment of invasive fungal infections
por: Wilson, Dustin T, et al.
Publicado: (2016)

Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients
por: Raffaelli, Francesca, et al.
Publicado: (2022)

Impact of ITS-Based Sequencing on Antifungal Treatment of Patients with Suspected Invasive Fungal Infections
por: Guenter, Sara, et al.
Publicado: (2020)

Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)

Efficacy and Safety of Combination Antifungals as Empirical, Preemptive, and Targeted Therapies for Invasive Fungal Infections in Intensive-Care Units
por: Yang, Qianting, et al.
Publicado: (2022)

Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies
por: Du, Wei, et al.
Publicado: (2021)

PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia
por: Taynton, Thomas, et al.
Publicado: (2022)

Systemic Antifungal Therapy for Invasive Pulmonary Infections
por: Ben-Ami, Ronen
Publicado: (2023)

The Changing Landscape of Invasive Fungal Infections in ICUs: A Need for Risk Stratification to Better Target Antifungal Drugs and the Threat of Resistance
por: Poissy, Julien, et al.
Publicado: (2022)

Epidemiology and Risk Factors for Invasive Fungal Infections in Pancreas Transplant in the Absence of Postoperative Antifungal Prophylaxis
por: Zachary, Jessica, et al.
Publicado: (2023)

Isavuconazole Treatment for Invasive Fungal Infections in Pediatric Patients
por: Zimmermann, Philippe, et al.
Publicado: (2022)

An Invertebrate Host to Study Fungal Infections, Mycotoxins and Antifungal Drugs: Tenebrio molitor
por: Canteri de Souza, Patrícia, et al.
Publicado: (2018)

Invasive fungal infections among critically ill children: Epidemiology, risk factors and outcomes
por: Hlophe, S T, et al.
Publicado: (2018)

Pediatric invasive fungal rhinosinusitis
por: Villamor, Perla, et al.
Publicado: (2023)

Vaccines for invasive fungal infections
por: Spellberg, Brad
Publicado: (2011)

Epidemiology and Antifungal Susceptibility Patterns of Invasive Fungal Infections (IFIs) in India: A Prospective Observational Study
por: Dabas, Yubhisha, et al.
Publicado: (2021)

Outpatient parenteral antifungal therapy (OPAT) for invasive fungal infections with intermittent dosing of liposomal amphotericin B
por: van de Peppel, Robert J, et al.
Publicado: (2020)

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
por: McEvoy, Kyle, et al.
Publicado: (2020)

Human Airway Epithelium Responses to Invasive Fungal Infections: A Critical Partner in Innate Immunity
por: Crossen, Arianne J., et al.
Publicado: (2022)

PC945, a Novel Inhaled Antifungal Agent, for the Treatment of Respiratory Fungal Infections
por: Murray, Alison, et al.
Publicado: (2020)

Mass Spectrometry-Based Proteomics of Fungal Pathogenesis, Host–Fungal Interactions, and Antifungal Development
por: Ball, Brianna, et al.
Publicado: (2019)

838. The Role of Surgery in the Management of Invasive Fungal Rhinosinusitis Complicated by Orbitocranial Extension in the Era of Azole Antifungals
por: Tessler, Idit, et al.
Publicado: (2023)

Anidulafungin in the treatment of invasive fungal infections
por: Sabol, Kathryn, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1nc3veggbdfaot78pg0jnrrv1f